Exact Mass: 277.0327

Exact Mass Matches: 277.0327

Found 60 metabolites which its exact mass value is equals to given mass value 277.0327, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Azathioprine

6-[(1-methyl-4-nitro-1H-imidazol-5-yl)sulfanyl]-7H-purine

C9H7N7O2S (277.0382)


Azathioprine is only found in individuals that have used or taken this drug. It is an immunosuppressive pro-drug. It is converted into 6-mercaptopurine in the body where it blocks purine metabolism and DNA synthesis.Azathioprine antagonizes purine metabolism and may inhibit synthesis of DNA, RNA, and proteins. It may also interfere with cellular metabolism and inhibit mitosis. Its mechanism of action is likely due to incorporation of thiopurine analogues into the DNA structure, causing chain termination and cytotoxicity. L - Antineoplastic and immunomodulating agents > L04 - Immunosuppressants > L04A - Immunosuppressants C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents C308 - Immunotherapeutic Agent > C574 - Immunosuppressant D009676 - Noxae > D000963 - Antimetabolites D000970 - Antineoplastic Agents D018501 - Antirheumatic Agents Azathioprine (BW 57-322) is an orally active immunosuppressive agent. Azathioprine can be converted in vivo to the active metabolite 6-mercaptopurine (6-MP). Azathioprine has myelosuppressive effects and induces apoptosis[1][3].

   

N-Phosphoguanidinoethyl methyl phosphate

N-phosphoguanidinoethyl methyl hydrogen phosphate

C4H13N3O7P2 (277.0229)


   

DOPA sulfate

(2S)-2-Amino-3-[4-hydroxy-3-(sulphooxy)phenyl]propanoic acid

C9H11NO7S (277.0256)


Increases in plasma dopamine sulfate and urinary dopamine suggest that dopamine sulfate may be generated via DOPA sulfate and urinary dopamine may originate from circulating DOPA. DOPA sulfate may be an alternative source of dopamine sulfate. Urinary dopamine progressively increased in the course of metyrosine treatment, and this, along with the increase of the dopamine metabolite, dihydroxyphenylethanol, and plasma dopamine sulfate, occurred in the absence of any change in plasma dopamine.(PMID: 1969915). Increases in plasma dopamine sulfate and urinary dopamine suggest that dopamine sulfate may be generated via DOPA sulfate and urinary dopamine may originate from circulating DOPA. DOPA sulfate may be an alternative source of dopamine sulfate.

   

Furilazole

2,2-Dichloro-1-[(5R)-5-(furan-2-yl)-2,2-dimethyl-1,3-oxazolidin-3-yl]ethan-1-one

C11H13Cl2NO3 (277.0272)


Furilazole (CAS: 121776-33-8) belongs to the class of organic compounds known as oxazolidines. Oxazolidines are compounds containing an oxazolidine moiety, which consists of a saturated aliphatic five-member ring with one oxygen atom, one nitrogen, three carbon atoms, and two double bonds. Furilazole is an extremely weak basic (essentially neutral) compound (based on its pKa). Furilazole is a dichloroacetamide herbicide safener for gramineous crops. Herbicide safener for gramineous crops

   

2-Chloro-5-nitro-N-4-pyridinylbenzamide

2-chloro-5-nitro-N-(pyridin-4-yl)benzamide

C12H8ClN3O3 (277.0254)


T0070907 is a potent PPARγ antagonist with a Ki of 1 nM.

   

(3,4-Dihydroxy-5-nitrophenyl)(2-fluorophenyl)methanone

(3,4-Dihydroxy-5-nitrophenyl)(2-fluorophenyl)methanone

C13H8FNO5 (277.0386)


   

Pluracidomycin D

Pluracidomycin D

C9H11NO7S (277.0256)


   

2-[2-(Acetyloxy)phenyl]-4-thiazolecarboxylic acid methyl ester

2-[2-(Acetyloxy)phenyl]-4-thiazolecarboxylic acid methyl ester

C13H11NO4S (277.0409)


   

T0070907

2-chloro-5-nitro-N-4-pyridinyl-benzamide

C12H8ClN3O3 (277.0254)


T0070907 is a potent PPARγ antagonist with a Ki of 1 nM.

   

azathioprine

"Azathioprine (Azasan, Imuran)"

C9H7N7O2S (277.0382)


L - Antineoplastic and immunomodulating agents > L04 - Immunosuppressants > L04A - Immunosuppressants C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents C308 - Immunotherapeutic Agent > C574 - Immunosuppressant D009676 - Noxae > D000963 - Antimetabolites D000970 - Antineoplastic Agents D018501 - Antirheumatic Agents CONFIDENCE standard compound; INTERNAL_ID 1262; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2581; ORIGINAL_PRECURSOR_SCAN_NO 2579 CONFIDENCE standard compound; INTERNAL_ID 1262; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2599; ORIGINAL_PRECURSOR_SCAN_NO 2597 CONFIDENCE standard compound; INTERNAL_ID 1262; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2587; ORIGINAL_PRECURSOR_SCAN_NO 2585 CONFIDENCE standard compound; INTERNAL_ID 1262; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2583; ORIGINAL_PRECURSOR_SCAN_NO 2581 CONFIDENCE standard compound; INTERNAL_ID 1262; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2606; ORIGINAL_PRECURSOR_SCAN_NO 2603 CONFIDENCE standard compound; INTERNAL_ID 1262; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2606; ORIGINAL_PRECURSOR_SCAN_NO 2604 CONFIDENCE standard compound; INTERNAL_ID 1262; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5597; ORIGINAL_PRECURSOR_SCAN_NO 5595 CONFIDENCE standard compound; INTERNAL_ID 1262; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5599; ORIGINAL_PRECURSOR_SCAN_NO 5597 CONFIDENCE standard compound; INTERNAL_ID 1262; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5624; ORIGINAL_PRECURSOR_SCAN_NO 5622 CONFIDENCE standard compound; INTERNAL_ID 1262; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5605; ORIGINAL_PRECURSOR_SCAN_NO 5603 CONFIDENCE standard compound; INTERNAL_ID 1262; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5625; ORIGINAL_PRECURSOR_SCAN_NO 5623 CONFIDENCE standard compound; INTERNAL_ID 1262; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5634; ORIGINAL_PRECURSOR_SCAN_NO 5633 CONFIDENCE standard compound; INTERNAL_ID 8328 Azathioprine (BW 57-322) is an orally active immunosuppressive agent. Azathioprine can be converted in vivo to the active metabolite 6-mercaptopurine (6-MP). Azathioprine has myelosuppressive effects and induces apoptosis[1][3].

   

DOPA sulfate

3,4-dihydroxy-L-phenylalanine 3-O-sulfate;L-3-hydroxytyrosine 3-sulfate;3-(3-sulfo-4-hydroxy-phenyl)-L-alanine

C9H11NO7S (277.0256)


   

Furilazole

2,2-dichloro-1-[5-(furan-2-yl)-2,2-dimethyl-1,3-oxazolidin-3-yl]ethan-1-one

C11H13Cl2NO3 (277.0272)


   

S-Methyl-L-thiocitrulline dihydrochloride

(S,E)-2-Amino-5-((amino(methylthio)methylene)amino)pentanoic acid dihydrochloride

C7H17Cl2N3O2S (277.0418)


   

(2-AMINO-4,7-DIMETHYL)BENZOTHIAZOL-6-OL,HCL

(2-AMINO-4,7-DIMETHYL)BENZOTHIAZOL-6-OL,HCL

C14H12ClNOS (277.0328)


   

chembrdg-bb 6966505

chembrdg-bb 6966505

C13H11NO4S (277.0409)


   
   

2-[(3,5-DICHLORO-2-HYDROXYBENZYLIDENE)AMINO]-2-METHYLPROPANE-1,3-DIOL

2-[(3,5-DICHLORO-2-HYDROXYBENZYLIDENE)AMINO]-2-METHYLPROPANE-1,3-DIOL

C11H13Cl2NO3 (277.0272)


   

3-BENZENESULFONYLAMINOBENZOICACID

3-BENZENESULFONYLAMINOBENZOICACID

C13H11NO4S (277.0409)


   

6-(4-Methanesulfonylphenyl)-nicotinic acid

6-(4-Methanesulfonylphenyl)-nicotinic acid

C13H11NO4S (277.0409)


   

4-(phenylsulfamoyl)benzoate

4-(phenylsulfamoyl)benzoate

C13H11NO4S (277.0409)


   

4-(2-Formylphenoxy)benzenesulfonamide

4-(2-Formylphenoxy)benzenesulfonamide

C13H11NO4S (277.0409)


   

5-(2-FURYL)-3-THIEN-2-YL-4,5-DIHYDRO-1H-PYRAZOLE-1-CARBOTHIOAMIDE

5-(2-FURYL)-3-THIEN-2-YL-4,5-DIHYDRO-1H-PYRAZOLE-1-CARBOTHIOAMIDE

C12H11N3OS2 (277.0344)


   

[3-(3-chloropropylsulfonylamino)phenyl]boronic acid

[3-(3-chloropropylsulfonylamino)phenyl]boronic acid

C9H13BClNO4S (277.0347)


   

1-[1-(CYCLOPROPYLMETHYL)-4-PIPERIDINYL]METHANAMINE

1-[1-(CYCLOPROPYLMETHYL)-4-PIPERIDINYL]METHANAMINE

C10H16BrNO3 (277.0313)


   

2-SULFAMOYL-BIPHENYL-4-CARBOXYLICACID

2-SULFAMOYL-BIPHENYL-4-CARBOXYLICACID

C13H11NO4S (277.0409)


   

3-Bromo-4-oxopiperidine-1-carboxylic acid tert-butyl ester

3-Bromo-4-oxopiperidine-1-carboxylic acid tert-butyl ester

C10H16BrNO3 (277.0313)


   

4-(n-(3-chloropropyl)sulfamoyl)phenylboronic acid

4-(n-(3-chloropropyl)sulfamoyl)phenylboronic acid

C9H13BClNO4S (277.0347)


   

2-Chloro-N-(2-phenylsulfanyl-phenyl)-acetamide

2-Chloro-N-(2-phenylsulfanyl-phenyl)-acetamide

C14H12ClNOS (277.0328)


   

Alipamide

Alipamide

C9H12ClN3O3S (277.0288)


C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic

   

Benzyltrimethylammonium iodide

Benzyltrimethylammonium iodide

C10H16IN (277.0327)


   

2-[difluoro(phenoxy)methyl]-1,3-benzothiazole

2-[difluoro(phenoxy)methyl]-1,3-benzothiazole

C14H9F2NOS (277.0373)


   

2-BENZENESULFONYLAMINO-BENZOIC ACID

2-BENZENESULFONYLAMINO-BENZOIC ACID

C13H11NO4S (277.0409)


   

2-(Methylsulfonyl)-10H-phenothiazine

2-(Methylsulfonyl)-10H-phenothiazine

C13H11NO2S2 (277.0231)


   

4-Chloro-3-cyano-7-ethoxy-6-nitroquinoline

4-Chloro-3-cyano-7-ethoxy-6-nitroquinoline

C12H8ClN3O3 (277.0254)


   

3-(4-Chloro-1H-pyrrolo[2,3-b]pyridin-5-yl)-N-methyl-1,2,4-oxadiaz ole-5-carboxamide

3-(4-Chloro-1H-pyrrolo[2,3-b]pyridin-5-yl)-N-methyl-1,2,4-oxadiaz ole-5-carboxamide

C11H8ClN5O2 (277.0366)


   

ETHYL 2-(BENZO[D][1,3]DIOXOL-5-YL)THIAZOLE-4-CARBOXYLATE

ETHYL 2-(BENZO[D][1,3]DIOXOL-5-YL)THIAZOLE-4-CARBOXYLATE

C13H11NO4S (277.0409)


   

3-(1-(phenylsulfonyl)-1H-pyrrol-2-yl)acrylic acid

3-(1-(phenylsulfonyl)-1H-pyrrol-2-yl)acrylic acid

C13H11NO4S (277.0409)


   

2-Chloro-N-(3-nitrophenyl)-4-pyridinecarboxamide

2-Chloro-N-(3-nitrophenyl)-4-pyridinecarboxamide

C12H8ClN3O3 (277.0254)


   

TERT-BUTYL (3,6-DICHLOROPYRIDAZIN-4-YL)METHYLCARBAMATE

TERT-BUTYL (3,6-DICHLOROPYRIDAZIN-4-YL)METHYLCARBAMATE

C10H13Cl2N3O2 (277.0385)


   

4-(PHENYLSULFONAMIDO)BENZOIC ACID

4-(PHENYLSULFONAMIDO)BENZOIC ACID

C13H11NO4S (277.0409)


   

(4-(1-piperidinylmethyl)phenyl)magnesiu&

(4-(1-piperidinylmethyl)phenyl)magnesiu&

C12H16BrMgN (277.0317)


   

N-(2-Chloropyridin-3-yl)-2-nitrobenzamide

N-(2-Chloropyridin-3-yl)-2-nitrobenzamide

C12H8ClN3O3 (277.0254)


   

(R)-2-(4-TRIFLUOROMETHYL-PHENYL)-THIAZOLIDINE-4-CARBOXYLIC ACID

(R)-2-(4-TRIFLUOROMETHYL-PHENYL)-THIAZOLIDINE-4-CARBOXYLIC ACID

C11H10F3NO2S (277.0384)


   

N-(4-formyl-3-hydroxyphenyl)benzenesulphonamide

N-(4-formyl-3-hydroxyphenyl)benzenesulphonamide

C13H11NO4S (277.0409)


   

(3-(1-piperidinylmethyl)phenyl)magnesiu&

(3-(1-piperidinylmethyl)phenyl)magnesiu&

C12H16BrMgN (277.0317)


   

Levodopa-4-monophosphate

Levodopa-4-monophosphate

C9H12NO7P (277.0351)


C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist

   

Durlobactam

Durlobactam

C8H11N3O6S (277.0369)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D065093 - beta-Lactamase Inhibitors C254 - Anti-Infective Agent > C258 - Antibiotic D004791 - Enzyme Inhibitors

   

Alrestatin sodium

Alrestatin sodium

C14H8NNaO4 (277.0351)


C471 - Enzyme Inhibitor > C72880 - Aldose Reductase Inhibitor

   

(3,4-Dihydroxy-5-nitrophenyl)(2-fluorophenyl)methanone

(3,4-Dihydroxy-5-nitrophenyl)(2-fluorophenyl)methanone

C13H8FNO5 (277.0386)


   

N-(7-methyl-2-thiazolo[4,5-g][1,3]benzothiazolyl)propanamide

N-(7-methyl-2-thiazolo[4,5-g][1,3]benzothiazolyl)propanamide

C12H11N3OS2 (277.0344)


   

3-[5-(3-Nitrophenyl)thiophen-2-yl]propanoic acid

3-[5-(3-Nitrophenyl)thiophen-2-yl]propanoic acid

C13H11NO4S (277.0409)


   

(alphaS)-alpha-Carboxy-2,3-dihydro-N,N,N-trimethyl-2-selenoxo-1H-imidazole-4-ethanaminium

(alphaS)-alpha-Carboxy-2,3-dihydro-N,N,N-trimethyl-2-selenoxo-1H-imidazole-4-ethanaminium

C9H15N3O2Se+ (277.0329)


   

2,6-Dimethyl-4-(3-thienyl)pyridine-3,5-dicarboxylic acid

2,6-Dimethyl-4-(3-thienyl)pyridine-3,5-dicarboxylic acid

C13H11NO4S (277.0409)


   

2-Nitrobenzaldehyde (3-chloro-2-pyrazinyl)hydrazone

2-Nitrobenzaldehyde (3-chloro-2-pyrazinyl)hydrazone

C11H8ClN5O2 (277.0366)


   

2-(p-Chlorophenyl)-3-ethyl-2,5-dihydro-5-oxo-4-pyridazinecarboxylate

2-(p-Chlorophenyl)-3-ethyl-2,5-dihydro-5-oxo-4-pyridazinecarboxylate

C13H10ClN2O3- (277.038)


   

1-[(5S)-2,2-Dimethyl-5-(2-furanyl)oxazolidin-3-yl]-2,2-dichloroethanone

1-[(5S)-2,2-Dimethyl-5-(2-furanyl)oxazolidin-3-yl]-2,2-dichloroethanone

C11H13Cl2NO3 (277.0272)


   

N-phosphoguanidinoethyl methyl hydrogen phosphate

N-phosphoguanidinoethyl methyl hydrogen phosphate

C4H13N3O7P2 (277.0229)


   

Selenoneine

Selenoneine

C9H15N3O2Se (277.0329)


A histidine derivative that is N(alpha),N(alpha),N(alpha)-trimethyl-L-histidine substituted by a selenoxo group at position 2 on the imidazole ring. A selenium-containing antioxidant found in tuna blood.

   

Oxazolidine, 3-(dichloroacetyl)-5-(2-furanyl)-2,2-dimethyl-, (5R)-

Oxazolidine, 3-(dichloroacetyl)-5-(2-furanyl)-2,2-dimethyl-, (5R)-

C11H13Cl2NO3 (277.0272)


   

6-(1-hydroxyethyl)-7-oxo-3-sulfo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid

6-(1-hydroxyethyl)-7-oxo-3-sulfo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid

C9H11NO7S (277.0256)